Top German Growth Companies With High Insider Ownership In October 2024
As Germany faces a challenging economic landscape with forecasts predicting a contraction in 2024, the country's stock market has shown resilience, evidenced by the DAX gaining 1.32% recently. In this environment, growth companies with high insider ownership can be particularly appealing as they often signal confidence from those closest to the business and may offer stability amidst broader economic uncertainties.
Top 10 Growth Companies With High Insider Ownership In Germany
Name | Insider Ownership | Earnings Growth |
Stemmer Imaging (XTRA:S9I) | 25% | 23.2% |
Exasol (XTRA:EXL) | 25.3% | 117.1% |
Deutsche Beteiligungs (XTRA:DBAN) | 39.6% | 54.1% |
adidas (XTRA:ADS) | 16.6% | 41.8% |
pferdewetten.de (XTRA:EMH) | 20.6% | 97.9% |
Alelion Energy Systems (DB:2FZ) | 37.4% | 106.6% |
R. STAHL (XTRA:RSL2) | 37.9% | 59.3% |
Friedrich Vorwerk Group (XTRA:VH2) | 18.8% | 24.6% |
Redcare Pharmacy (XTRA:RDC) | 17.4% | 54.3% |
elumeo (XTRA:ELB) | 25.8% | 123.5% |
Here we highlight a subset of our preferred stocks from the screener.
Brockhaus Technologies
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Brockhaus Technologies AG is a private equity firm with a market capitalization of approximately €290.45 million.
Operations: The company's revenue is primarily derived from its Security Technologies segment, which generated €37.03 million, and its Financial Technologies segment, contributing €174.59 million.
Insider Ownership: 26.6%
Brockhaus Technologies, with high insider ownership, is poised for significant growth as its revenue is forecast to expand at 16.8% annually, outpacing the German market average of 5.5%. Despite a current net loss of €6.65 million for H1 2024, the company aims to achieve profitability within three years. Trading significantly below fair value enhances its appeal as a growth stock in Germany's tech sector. Recent earnings guidance confirms robust revenue targets through 2025.
Redcare Pharmacy
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Redcare Pharmacy NV operates an online pharmacy business across the Netherlands, Germany, Italy, Belgium, Switzerland, Austria, and France with a market cap of €2.92 billion.
Operations: The company's revenue is divided into two primary segments: DACH, contributing €1.74 billion, and International, generating €391 million.
Insider Ownership: 17.4%
Redcare Pharmacy, with substantial insider ownership, is positioned for growth as its revenue is expected to increase at 17.5% annually, surpassing the German market average of 5.5%. Despite a net loss of €12.07 million in H1 2024, the company anticipates profitability within three years and has raised its sales guidance for 2024 to between €2.35 billion and €2.5 billion. Trading well below estimated fair value adds to its growth potential in Germany's pharmacy sector.
Friedrich Vorwerk Group
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Friedrich Vorwerk Group SE offers solutions for the transformation and transportation of energy in Germany and Europe, with a market cap of €513 million.
Operations: The company's revenue segments include €95.30 million from electricity, €160.89 million from natural gas, €28.38 million from clean hydrogen, and €117.28 million from adjacent opportunities.
Insider Ownership: 18.8%
Friedrich Vorwerk Group SE, with significant insider ownership, has demonstrated robust growth, reporting a substantial increase in net income from €2.38 million to €7.96 million in Q2 2024. The company forecasts annual earnings growth of 24.63%, outpacing the German market's average of 20%. Revenue is expected to exceed €410 million for fiscal year 2024, indicating at least a 10% rise from the previous year, driven by strong performance and strategic guidance updates.
Seize The Opportunity
Explore the 20 names from our Fast Growing German Companies With High Insider Ownership screener here.
Already own these companies? Link your portfolio to Simply Wall St and get alerts on any new warning signs to your stocks.
Unlock the power of informed investing with Simply Wall St, your free guide to navigating stock markets worldwide.
Ready For A Different Approach?
Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
Find companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.
Companies discussed in this article include XTRA:BKHT XTRA:RDC and XTRA:VH2.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]